SETD7 and prostate adenocarcinoma: Based on The Cancer Genome Atlas (TCGA) datasets of pan-cancer, there are as many as 11 types of cancers with high SETD7 expression, which are diffuse large B cell lymphoma (DLBC), Esophageal carcinoma (ESCA), Glioblastoma multiforme (GBM), Kidney renal clear cell carcinoma (KIRC), Kidney renal papillary cell carcinoma (KIRP), Acute Myeloid Leukemia (LAML), Brain Lower Grade Glioma (LGG), Pancreatic adenocarcinoma (PAAD), Prostate adenocarcinoma (PRAD), Stomach adenocarcinoma (STAD) and Thymoma(THYM) (Fig. 1A).